Home > Boards > US Listed > Medical - Drugs > GlaxoSmithKline (GSK)

Breaking News: $GSK Investors Wish They Could Vote

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
 
Followed By 115
Posts 15,030
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
CureVac right-sizes COVID-19 vaccine manufacturing in response to changes in demand Seeking Alpha - 9/14/2021 8:10:27 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/13/2021 1:49:57 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/9/2021 12:36:10 PM
Dosing underway in Alector's Phase 2 AL001 study in amyotrophic lateral sclerosis Seeking Alpha - 9/9/2021 9:44:57 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/7/2021 1:38:17 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/3/2021 7:19:10 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/1/2021 9:12:53 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/31/2021 8:04:42 AM
GlaxoSmithKline, SK Bioscience Begin Phase 3 Trial of Covid-19 Vaccine Dow Jones News - 8/31/2021 2:50:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/25/2021 9:44:47 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/23/2021 12:55:49 PM
Merck KGaA halts mid-stage trial for bintrafusp alfa in biliary tract cancer Seeking Alpha - 8/23/2021 12:03:22 PM
AnaptysBio Up 10% on GSK Drug Indication Approval Dow Jones News - 8/17/2021 6:50:00 PM
Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a) Edgar (US Regulatory) - 8/13/2021 7:07:24 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/11/2021 10:02:12 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/11/2021 8:50:54 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/5/2021 7:30:18 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/2/2021 9:47:56 AM
GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps Business Wire - 7/29/2021 6:03:00 PM
GlaxoSmithKline announces FDA approval of Nucala for new eosinophilic-driven indication Seeking Alpha - 7/29/2021 3:04:24 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 7/28/2021 1:36:39 PM
GlaxoSmithKline 2Q Net Profit Fell Despite Higher Sales; Backs 2021 Outlook -- Update Dow Jones News - 7/28/2021 8:52:00 AM
GlaxoSmithKline posts Q2 earnings beat, maintains FY forecast Seeking Alpha - 7/28/2021 8:20:29 AM
GlaxoSmithKline 2Q Net Profit Drops Despite Higher Sales; Backs 2021 Outlook Dow Jones News - 7/28/2021 7:39:00 AM
GlaxoSmithKline, Vir Biotechnology to Supply Covid-19 Treatment to European Commission Dow Jones News - 7/28/2021 7:18:00 AM
whytestocks   Sunday, 11/15/20 02:15:20 PM
Re: None
Post # of 167 
Breaking News: $GSK Investors Wish They Could Vote These 2 Healthcare CEOs Out

One of the best things about a democracy is getting to vote out representatives who let us down. As shareholders, it's much harder to express dissatisfaction in management without just selling shares, since you may really like the business despite management.  But some investors might ...

Read the whole news GSK - Investors Wish They Could Vote These 2 Healthcare CEOs Out

@whytestocks
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences